hVIVO, the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its plans for a new larger facility at the fast-growing life sciences hub in Canary Wharf, London. The expansion, largely funded by hVIVO clients, comes in response to the company’s growing orderbook and increasing demand for its human
